Fundamental and clinical studies on cefminox sodium in the field of oral surgery.
スポンサーリンク
概要
- 論文の詳細を見る
Fundamental and clinical studies were carried out on CMNX, a new cephamycin antibiotics. The results were as follows:<BR>1) The concentration of this antibiotics in serum, gingiva and jaw bone tissues was measured after an intravenous one shot injection of 1 g of CMNX on a patient. The mean serum, gingiva, and jaw bone tissue concentration were 47.7 μg/ml, 18.5 μg/g, 7.3 μg/g at 1 h, respectively.<BR>2) <I>In vivo</I> antibacterial activity of CMNX was studied on 50 clinical isolates to CMNX. CMNX had a wide spectrum of antibacterial activity against gram-positive and gram-negative bacteria. The MIC<SUB>80</SUB> against aerobes was 12.5 μg/ml, and against anaerobes was 6.3 μg/ml.<BR>3) The clinical efficacy of CMNX was 95% based on committee judgement and 86% based on doctors' judgement.<BR>4) From the above results, it was concluded that CMNX was a useful new antibiotic in the field of oral surgery.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果